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Summary
Dermatitis herpetiformis (DH) shares some clinical features and major histocompatibility complex
(MHC) markers with gluten-sensitive enteropathy (GSE) . We compared MHC haplotypes in
27 patients with DH, 35 patients with GSE, and normal controls. As in GSE, the frequencies
of two extended haplotypes, [HLA-B8, SC01, DR3] and [HLA-B44, FC31, DR7], were increased
in patients with DH. Distributions of fragments of extended haplotypes, consisting of some
but not all ofthe elements ofcomplete extended haplotypes, were analyzed to attempt to localize
a susceptibility gene. Besides complete extended susceptibility haplotypes, (DR3, DQ2) and (DR7,
DQ2) fragments were most common in GSE. In contrast, DH showed only a few such fragments
but many instances of the fragment (SC01) . The differences in distribution of these fragments
in the two diseases were highly significant (P <0.002). HLA-DQ2 and DR3 had the highest
odds ratios for GSE, but the highest odds ratio for DH was for the complotype SCOL These
findings suggest that the MHC susceptibility gene for DH is between class II and complotype
regions, closest to the complotype, whereas that for GSE is in the class lI region.
D
ermatitis herpetiformis (DH)' is a chronic pruritic
papulo-vesicular disease of the skin characterizedby the
granular deposition ofI&A in the dermal papillae and by patchy
focal asymptomatic villous atrophy of the small intestine (1,
2). In Caucasian patients, there is a marked increase in HLA-
B8, DR3, and DQ2 (3-7) . These genes are components of
the fixed conserved extended haplotype [HLA-B8, SC01,
DR31 (8). The recent report of an increase in HLA-DPI (9)
in patients with DH who carry markers of this haplotype
may be secondary to their known linkage disequilibrium in
general (10, 11). A less striking increase in HLA-Dw7 in DH
patients has also been reported (12). The same HLA markers
have been noted to be increased in celiac disease (gluten-
sensitive enteropathy [GSE]) (13-16) . Moreover, patients with
DH and GSE share a number ofother features, such asjejunal
atrophy correctable by elimination of gliadin from the diet,
i Abbreviations used in this paper: DH, dermatitis herpetiformis; GSE,
gluten-sensitive enteropathy.
2067
and the presence of anti-a-gliadin (17, 18) and antireticulin
(19, 20) antibodies. We have reported family studies in GSE
(21) that show that all increased available HLA markers are
parts of two extended haplotypes: [HLA-B8, SC01, DR3]
and [HLA-B44, FC31, DR7].
Previous studies of DH have almost exclusively reported
HLA phenotypes in patients rather than haplotypes deter-
mined in family studies. Haplotype comparisons, including
analysis for complotypes and other MHC genes, are critical
to localizing candidate susceptibility genes, and we under-
took such studies in patients with DH. We present these results
in this report and compare these DH haplotypeswith those
derived from our earlier studies in GSE. Our results suggest
that, despite the similarityof individual MHC allele markers
for GSE and DH, the susceptibility genes for the two dis-
orders are different. That for GSE appears to be in or near
the HLA-DR/DQ region, whereas that for DH appears to
be between complement and DR/DQ, closest to the com-
plement region.
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Samples.
￿
Blood from 27 randomly ascertained Caucasian pa-
tients with dermatitis herpetiformis and 147 of their first-degree
relatives was collected into 7-ml Vacutainer tubes (Becton Dick-
inson & Co., Rutherford, NJ) containing 10.5 mg of potassium
EDTA and into syringes containing 500-1,000 U of sodium heparin
diluted with an equal volume of RPMI 1640. 25 patients were un-
related; 2 (43416 and 43417) were siblings. Lymphocytes were sepa-
rated from heparinized blood by Ficoll-Hypaque centrifugation,
frozen, and stored in vapor phase liquid nitrogen untilthawed for
HLA analysis. Plasma separated from blood anticoagulated with
EDTA was stored at -80°C untiljust before analysis for comple-
ment types.
Patients.
￿
All patients with DH had a historyof and on physical
examination had evidence of typical pruritic grouped vesicles on
extensor surfaces oflimb skin. The diagnosis ofDH was confirmed
by the presence ofgranular deposits of IgA by direct immunofluores-
cence microscopy in the dermal papillae of perilesional skin (22).
35 patients with GSE were studied, of which 24 were reported
earlier (21).
MHC Marker Studies.
￿
HLAA, B, DR, and DQ typing were
by standard assays (23, 24). Plasma samples were analyzed for genetic
polymorphism in C2 (25), in factor B (BF) (26), and in C4 (27)
by methods previously described. Complotypes are haplotypes of
specific alleles of these four closely linked loci and are designated
in arbitrary order by theirBF, C2, C4A, and C4B alleles, including
QO for null alleles (28). Thus, FC30 stands forBF*F, C2*C, C4A*3,
and C4B*Q0.
HaplotypeAnalysis.
￿
Alleles were assigned to haplotypes on the
basis offamily studies except for sequence-specific oligonucleotide-
determined alleles, which were studied only in patients. The two
DH-affected siblings were MHC haploidentical and thus contributed
three independent disease haplotypes to the analysis.
Class77(HLA-DR, DQ andDP)Allele Typing.
￿
Genomic DNA
was isolated from PBL or from EBVtransformed cell lines of 17
DH patients and 10 GSE patients. Sequence-specific oligonucleo-
tide (SSO) probe hybridization was carried out according to the
protocols of the 11th International Histocompatibility Workshop
(11). Briefly, PCR amplifications were carried out on 0.6-,ug samples
of purified genomic DNA in a 100-Al reaction mixture containing
50 pmol of each primer, 50 mM KCI, 10 mM Tris-HCI, pH 8.3,
0.2 mM of each deoxynucleotide, 2.5 U of Taq polymerase (Promega
Biotec, Madison, WI), and 1.5 mM MgC12. The primers used
were those recommended by the 11th Workshop. About 50 ng of
amplified DNA was spotted on several nylon membranes. These
were prehybridized at 54*C with hybridization buffer (50 mM Tris
HCl, 3 M tetramethyl ammonium chloride, 2 mM EDTA, 0.1%
SDS, 100 mg/mlheat-denatured herring sperm DNA, and 5 x Den-
hardt's solution) for 1 h. The allele-specific oligonucleotides labeled
with y-[32P]ATP were added. HLA-DRB1, -DQA1, -DQB1, and
-DPB1 alleles were identified after incubation, washing, and auto-
radiography of the exposed membranes. Haplotype assignments were
deduced from known linkage disequilibria for all loci but DPB1.
The order of genes in the MHC from telomere to centromere is
HLA-A, B, complotype, DR, DQ, and DP.
Statistical Analyses.
￿
Statistical significance of the differences in
frequency of individual MHC alleles and extended haplotypes in
the patient and control populations of haplotypes was estimated
by XZ analysis or by Fisher's exact test, as appropriate. Since prior
work has shown elements of [HLA-B8, SC01, DR3, DQ2] and
[HLA-B44, FC31, DR7, DQ2] to be elevated among patients, no
corrections were applied to p values for significance of differences
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in frequency from normals. Two kinds of control haplotypes were
used, family and overall Caucasian controls (29) .
Results
MHC Haplotypes in DH.
￿
MHC haplotypes occurring in
27 patients with DH are shown in Table 1. All but nine haplo-
types contained elements of one or the other oftwo extended
conserved MHC haplotypes, [HLA-B8, SC01, DR3] or
[HLA-B44, FC31, DR7]. The patient haplotypes were ar-
ranged in Table 1 in relation to these extended haplotypes
and theirfragments from telomeric to centromeric. Two haplo-
types, 42453b and 43655b, had elements of both extended
haplotypes and are shown in each category. The arrangement
permits the easy identification of fragments of the extended
haplotypes. Thus, there were 22 instances of the complete
[HLA-B8, SC01, DR3] extended haplotype and 10 examples
offragments ofthis haplotype. Of the fragments, there were
two examples of (SC01, DR3) without B8, and single ex-
amples of B8 without SC01 or DR3, (B8, SC01) without
DR3, and DR3 without SCOL In contrast, there are five
cases of (SCOT) without B8 or DR3. Because HLA-DQ2,
in strong linkage disequilibrium with both DR3 and DR7,
was also increased markedly (see below), these findings sug-
gest that the susceptibility gene lies between the complo-
type region and HLA-DR/DQ.
Of the 16 haplotypes related to [HLA-B44, FC31, DR7],
there were 3 instances of the complete extended haplotype.
Of the 13 cases of fragments, 5 had HLA-B44 and complo-
types other than FC31, 6 had DR7 but not FC31 (2 of these
had SC01), 2 had (FC31, DR7) but not HLA-B44, there was
1 instance of (FC31) alone, and 6 with (DR7, DQ2) alone.
These findings are consistent with the possibility that a sus-
ceptibility gene lies in the complotype-DR/DQ region of
the MHC. In keeping with these conclusions was the finding
that all (27/27) patients carried SC01 or FC31 and almost
all carried HLA-DQ2 (26/27) and DR3 or DR7 (26/27) .
MHC Class 17 Alleles Defined by Sequence-specific Oligonu-
cleotide Typing. HLA-DRB1, DQA1, and DQB1 alleles are
listed in Table 2 for patients with DH. In all instances, the
DQA1 and DQB1 alleles present conformed to the DRB1
alleles predicted from known essentially invariablelinkage dis-
equilibria in Caucasians. Of the 27 DH patients, 21 carried
the DRB1*0301, DQA1*0501, DQB1*0201 haplotype found
on all HLA-DR3 haplotypes and instances of[HLA-B8, SC01,
DR3]. Of the six patients who did not, three were DRBl*11,
DQA1*0501, DQB1*0301/DRB1*07, DQA1*0201, DQB1*-
0201 heterozygotes, and one each were heterozygotes for
DRB1*0103, DQA1*0101, DQB1*0501/DRBI*07, DQAl*-
0201, DQB1*0201; DRBl*0101, DQA1*0101, DQBl*0501/
DRB1*04, DQA1*0301,DQB1*0302, and DRB1*04, DQA1*-
0301, DQBi*0302/DRBI*07, DQA1*0201, DQB1*0303.
The overall distribution ofDR specificity homozygotes and
heterozygotes was not different from that predicted from the
Hardy-Weinberg distribution.
The frequency of HLA-DPBl*0101 (6/28) was increased
(p <0.003) among DH haplotypes compared with the fre-Shown are all specificities assigned to haplotypes by family study.
Listed twice as related to both [HLA-B8, SCOI, DR31 and [HLA-B44, FC31, DR71.
$Extended haplotypes other than those above.
quency of 3 of 105 amongrandom normal Caucasian haplo-
types in our laboratory. 2 of the 3 DPB1'0101 among con-
trol chromosomes were carried by [HLA-B8, SCO1, DR3]
and 18 of 52 [HLA-B8, SCO1, DR3] homozygous typing
cell haplotypes carried DPB1"0101 (p <2 x 10-7), indica-
tive of strong linkage disequilibrium between DPB1"0101
and [HLA-B8, SC01, DR3]. Six of six instances of the
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DPB1"0101 allele occurred in patients whocarried DR3 haplo-
types, of which five were the complete extended haplo-
type [HLA-B8, SCO1, DR3] and one was the (SC01, DR3)
fragment .
MHC Specificity and Haplotype Frequencies in Patients with
DH Compared with ControlHaplotypes. Table 3 gives the fre-
quencies in patients with DH of MHC alleles and extended
Table 1. MHC Haplotypes in Patients with DH
Haplotype
No.
HLA-
A B Complotype HLA-DR
Haplotype
No.
HLA-
A B Complotype HLA-DR
Haplotypes related to
[HLA-B8, SCO1, DR3]:
42306a 2 8 SC32 4 Haplotypes related to
41019a _1 8 SCOT 3 [HLA-B44, FC31, DR7]:
42290a 1 8 scol 3 41019c 2 44 SC30 1
42372c 1 8 SCOT 3 42290c 24 44 FC30 6
42388d 1 8 SCOT 3 42297c 2 44 SC31 5
42394d 1 8 SCOT 3 42439b 32 44 FC(3,2)0 1
42439a 1 8 scol 3 43998b 28 44 SC31 _7
42445c 1 8 scol 3 42359a 23 44 FC31 7
42447a 1 8 SCOT 3 43376a 26 44 FC31 7
43342b 1 8 SCOT 3 42372d 11 44 FC31 7
43406a 1 8 SCOT 3 42297d 3 7 FC31 7
43411a 1 8 SCOT 3 43398a 2 7 FC31 7
43411c 1 8 SCOT 3 42388c 2 57 FC31 5
43416a 1 8 scol 3 43352b 3 47 FC91,0 7t
43998a 1 8 SCOT 3 42453b 2 13 SCOT 7"
44026b 1 8 scol 3 42312a 1 57 SC61 V
42399a 2 8 SCOT 3 42338c 2 13 SC31 7
43352a 2 8 SCOT 3 43655b 11 8 SCOT 7'
42306b 2 8 SCOT 3
42301a 3 8 SCOT 3
42394c 11 8 SCOT 3
43342a 24 8 SCOT 3 Other haplotypes :
42338a 25 8 SCOT 3 43406c 23 7 SC31 1
43655b 11 8 SC01 7" 43902a 11 56 SC31 1
43417d 2 7 SCOT 3 43416c 3 7 SC61 2
43376c 11 27 SCOT 3 42301b 3 7 SC31 2t
42312b 2 49 scol 4 42399d 25 18 S042 2#
43902c 2 49 SCOT 4 44026a 1 60 SC31 4
42447c 3 7 SCOT 1 43655a 2 51 SC30 5
42453b 2 13 SCOT 7" 43398c 1 35 SC42 6
42359b 2 61 SCOT 5 42445a 3 35 SC42 6
42453a 1 7 SC31 3haplotypes ofinterest or those showing significant differences
from the frequencies in control haplotypes. There were striking
increases in the frequencies of the extended conserved MHC
haplotype [HLA-B8, SC01, DR3] and all of its elements,
including HLA-B8, SC01, C4A*Q0, HLA-DR3, and
HLA-DQ2.
Comparison of MHC Haplotypes in Patients with DH with
Those in Patients with GSE. Table 4 lists MHC haplotypes
in 35 patients with GSE. In the two groups of patients, only
HLA-A29 was higher in GSE (p = 0.012) and only HLA-
DR1 was higher in DH (p = 0.018) among all alleles and
extended haplotypes compared. These differences were only
nominally significant and lost significance aftercorrection for
the number ofcomparisons. HLA-DRBI, DQA1, and DQB1
alleles observed among GSE patients were those predicted
by known linkage disequilibria with generic DR types.
Because so many ofthe DH patient haplotypes were related
to [HLA-B8, SC01, DR3], analyses of the distribution of
alleles and haplotypes were carried out after the removal of
the complete [HLA-B8, SC01, DR3] haplotype from all pa-
tient and control haplotypes. The increases in patients' SC01,
C4A'Q0, and HLA-DQ2 remained highly significant. In ad-
dition, the increase in [HLA-B44, FC31, DR7] among DH
patient haplotypes wasjust significant (compared with family
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DRBI-DQA1-DQB1 haplotype assignments deduced from known linkage disequilibria. Because linkage relationships o£ DR,DQ-DPB1 alleles are
weaker, no assignments were made.
1101 or 1104.
controls but not to overall controls) at p <0.05. By them-
selves, these observations suggested that the chromosomal
region between SC01 and HLA-DQ2 contains susceptibility
gene(s) for DH.
Odds ratios for MHC alleles and haplotypes in the DH
and GSE patient and control populations with and without
patients positive for the complete [HLA-B8, SC01, DR3]
extended haplotype were calculated and the results are given
in Table 5 . It is seen that for DH the highest odds ratio with
and without the extended haplotype was that of SC01 fol-
lowed by that of HLA-DQ2, whereas in GSE it was DQ2
followed by DR3.
The distribution of fragments of [HLA-B8, SC01, DR3]
among 55 DH patient haplotypes (Table 1) was compared
with those among 70 GSE patient haplotypes (Table 6). In
DH, there were six haplotypes with SC01 but not DR3 and
only one haplotype with DR3 but not SC01, whereas in GSE
there were no haplotypes with SC01 but not DR3 and eight
haplotypes with DR3 but not SC01 (p <0.002), as shown
in Table 6.
We had earlier noted that in patients with GSE, HLA-A1
was less frequently found on [HLA-B8, SC01, DR3] than
on control haplotypes (Table 4). This phenomenon was not
seen in patients with DH (Table 1), in whom 16 of 22 in-
Table 2.
Patient
HLA-DRBI,
DRBI
DQA1, DQBI, and DPB1
First haplotype
DQA1
Alleles in
DQB1
Patients with DH
DRBI
Second
DQA1
haplotype
DQB1 DPB1
43902 0101 0101 0501 04 0301 0302 ND
43342 0301 0501 0201 0301 0501 0201 ND
43411 0301 0501 0201 0301 0501 0201 ND
43406 0301 0501 0201 0101 0101 0501 0101/1201
42439 0301 0501 0201 0101 0101 0501 0301/0401
42399 0301 0501 0201 1501 0102 0602 0101/1901
43416 0301 0501 0201 1501 0102 0602 0401/0401
42306 0301 0501 0201 04 0301 0201 0101/0301
43998 0301 0501 0201 07 0201 0201 0101/1101
42447 0301 0501 0201 07 0201 0201 0301/0401
43376 0301 0501 0201 07 0201 0201 0101/1001
42453 0301 0501 0201 07 0201 0201 0401/0501
43352 0301 0501 0201 07 0201 0201 0101/1501
43398 07 0201 0201 0103 0101 0501 0301/0402
42312 07 0201 0303 04 0301 0302 0401/0401
42359 07 0201 0201 11"` 0501 0301 0301/0401
43655 07 ND 0201 11' ND 0301 0401/0701Table 3.
￿
Comparison of MHC Allele Frequencies in Patients with DH with Controls
Only alleles or haplotypes of interest or showing significant differences in frequency among the populations of haplotypes are shown.
stances carried HLA-A1, a similar fraction as in normal [HLA-
B8, SCO1, DR3] haplotypes (p = NS).
Discussion
Family
Our observations strongly suggest that the major suscep-
tibility genes within the MHC for GSE and DH are different,
or at least has different locations, in spiteof the fact that the
two disorders share clinical features and similar MHC markers,
including extended haplotypes. That for GSE appears to lie
in the DR/DQregion, whereas that for DH is near the com-
plotype region, perhaps between it and DR/DQ.
As previously reported (21), all of the HLA markers for
GSE are derived from two conserved or extended haplotypes,
[HLA-B8, SCO1, DR3j and [HLA-B44, FC31, DR7]. It is
evident that for both HLA-DR3, DQ2- and HLA-DR7,
DQ2-bearing haplotypes that (DR, DQ) fragments of the
complete extended haplotypes were specifically enriched over
(HLA-B, complotype), (complotype), or (complotype, DR,
DQ) fragments in GSE. These findings support the concept
that a gene in the DR, DQ region, probably a class II gene,
is the susceptibility gene for GSE.
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Normal
Even though MHC markers among DH patient haplo-
types were very similar and the same extended haplotypes
were increased as in GSE, the (SC01) fragment was specifically
enriched over (B8, SCO1), (SCO1, DR3, DQ2), and (DR3,
DQ2). Furthermore, there was only one haplotype with DR3
but not SCOT, but six with SC01 but not DR3. SC01 had
the highest odds ratioof any MHC marker in DH, including
DQ2. All of these points support the conclusion that the
DH susceptibility gene is near SCOT. This was in contrast
to GSE, in which DQ2 had the highest odds ratio.
The findings with respect to DH haplotypes related to
[HLA-B44, FC31, DR7] were less clear cut in that both HLA-
B44 and DR7 alone were often (and roughly equally) found
and only one (FC31) alone occurred among patient haplo-
types. Nevertheless, the presence of several instances of the
(FC31, DR7, DQ2) fragment suggests that the susceptibility
gene on this haplotype, too, may be between the complo-
types and DR regions. Although ethnic differences between
DH and GSE patients might affect the extent of fragmenta-
tion of the relevant extended haplotypes (30, 31), this would
not in itselfbe expected to result in enrichment of some specific
fragments over others.
Allele No.
Patient
frequency
Fraction No .
control
frequency
Fraction No.
control
frequency
Fraction
pt vs.
fc
Pt vs.
nc
P P
HLA-A1 19 0.352 11 0.190 378 0.174 <0.05 0.0010
HLA-B8 24 0.444 4 0.069 265 0.122 <0.0001 0.0001
HLA-B15 0 0.000 5 0.086 121 0.056 <0.04 NS
HLA-DR2 3 0.056 7 0.121 354 0.162 NS <0.02
HLA-DR3 23 0.426 7 0.121 290 0.133 0.0001 0.0001
HLA-DR4 4 0.074 6 0.103 373 0.171 NS <0.02
C4A'QO 29 0.537 7 0.121 360 0.165 0.0001 0.0001
C4A'2 0 0.000 1 0.017 133 0.061 NS <0.04
C4A"3 18 0.333 37 0.638 1,319 0.605 0.0010 0.0001
C4B' 1 45 0.833 37 0.638 1,530 0.702 0.02 NS
SCOT 29 0.537 6 0.103 293 0.134 0.0001 0.0001
SC31 8 0.148 19 0.328 820 0.376 <0.03 0.0001
[B8,SCO1,DR3] 22 0.407 3 0.052 192 0.088 <0.0001 0.0001
[B44,FC31,DR7] 3 0.056 0 0.000 63 0.029 NS NS
Total 54 58 2,180
DQ1 10 0.208 21 0.396 192 0.420 <0.05 0.004
DQ2 31 0.646 17 0.321 109 0.239 0.001 0.0001
DQ3 7 0.146 15 0.283 155 0.339 NS 0.006
Total 48 53 457Table 4.
￿
MHC Haplotypes in Patients with GSE
HLA-
￿
HLA-
Haplotype
￿
Haplotype
no. A B Complotype HLA-DR no. A B Complotype HLA-DR
Listed twice as related to both [HLA-B8, SCO1, DR3] and [HLA-B44, FC31, DR7].
$Extended haplotype other than those above.
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Haplotypes
(HLA-B8,
related to
SC01, DR3) :
Haplotypes
(HLA-B44,
related to
FC31, DR7):
38756d 24 _8 FC31 _3` 42136b 2 44 SC30 3'
40713a 3 7 SC01 3 40713c 2 44 SC(3,905)1 3"
35788c 1 8 SC01 3 38584c 2 44 SC30 5
37001b 1 8 SC01 3 35204b 29 44 SC61 6
38263c 1 8 SC01 3 38756d 24 8 FC31 3`
38313a 1 8 SCOT 3 11146c 29 44 FC31 7
38506a 1 8 SC01 3 11245a 29 44 FC31 7
38619a 1 8 SC01 3 11260c 29 44 FC31 7
38647c 1 8 SCOT 3 38263a 29 44 FC31 7
39987a 1 8 SCOT 3 11278c 2 44 FC31 7
40709c 1 8 SC01 3 38572c 2 44 FC31 7
40771a 1 8 SC01 3 38619c 2 44 FC31 7
42613c 1 8 SC01 3 38623c 28 44 FC31 7
42613d 1 8 SC01 3 37001d 25 18 FC31 7
44417c 1 8 SCOT 3 37925c 26 45 FC01 7
11245c 2 8 SCOT 3 40777d 30 58 FC01 _7
11263c 2 8 SC01 3 11263a 33 44 SC31 _7
38506c 2 8 SC01 3 11146a _1 57 SC61 _7#
40709a 2 8 SCOT 3 34986a 30 13 SC31 _7
40777a 2 8 SCOT 3 36051a 2 13 SC31 7
43870c 2 8 SCOT 3 35811c 24 22 SC31 _7
38668c 3 8 SCOT 3 38553a 29 14 SC31 7
38668a 24 8 SC01 3 40771c 2 62 SC33 _7
35017a 24 8 SC01 3 42629b - 51 SIC3,17 _7
37925a 25 8 SCOT 3 44440c 11 44 SC31 _7
11278a 28 8 SCOT 3 Other haplotypes:
11260a 28 8 SCOT 3 38584a 3 7 SC31 2#
34986c 32 8 SCOT 3 44417a 1 7 SC31 2t
38756c 29 8 SC01 3 35017c 2 60 SB42 0
38623a 34 8 SC01 3 38647a 2 62 SB42 4t
35204a 2 18 FIC30 3# 42136e 3 60 SC31 4
35788d _1 57 SC61 _3 43870a 26 35 SC31 4t
35811a 11 39 SC42 3 36051c 26 14 SC31 5
42136b 2 44 SC30 3- 38313c 30 38 SC31 5
38553c 3 7 SC31 _3 38572a 24 51 SC31 5
40713c 2 44 SC(3,905)1 _3" 44440a 69 55 SC30 5
42629d 26 63 SIC2(1,17) 3 39987c 11 51 FC(3,2)0 6Table 5.
￿
Odds Ratios of MHC Alleles in Patients with DH and GSE with and without Removal of [HLA-138, SC01, DR3]
Odds ratios are for subjects positive for the marker.
Dermatitis herpetiformis
odds ratio
p <0.002.
We believe that there are a number of susceptibility genes
for DH and a number for GSE at a single locus for each dis-
ease acting in an essentially, but not simply, recessive manner.
Others have found that DR4 haplotypes may contribute
"minor" susceptibility to GSE (32). From our results, the
major susceptibility markers for GSE are DR3, DQ2 and
DR7, DQ2, and the minor markers are DR4, DQ7; DR5,
DQl; DR2, DQ1; and DR6, DQ1. We cannot, however,
rule out 2 distinct MHC susceptibility loci (DQ and DP
related) in GSE and three (complotype, DR/DQ, and DP
related) in DH. Against the latter possibility is the presence
primarily of (DR3, DQ2) and (DR7, DQ2) but not (FC31)
or (SC01) in GSE and SCO1, rather than chiefly class II frag-
ments in DH patient haplotypes. If both DQ and complo-
type genes were required for recessive expression, the minimum
fragment should contain both complotype and DQ suscepti-
bility genes.
The relatively greater diversity of HLA-A alleles on [HLA-
B8, SCOT, DR3] haplotypes in GSE compared with the same
haplotypes in DH patients or normals, in whom 75-80%
of instances carry HLA-Al, may reflect the susceptibility gene
localization results. Since there was enrichment for DR, DQ
fragments in GSE, one might expect less homogeneity of
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Gluten-sensitive enteropathy
odds ratio
the HLA-A region which is 2 x 106 base pairs telomeric
to the classII region. It follows that if the susceptibility locus
is near the complotype region, perhaps between the latter
and DR, DQ, this may result in the observed higher HLA-
Al frequency on [HLA-138, SCO1, DR3] in DH than in GSE.
Recent studies have raised the possibility ofspecific HLA-
DP alleles being associated with GSE (33-35) and DH (36).
Our finding of an increase in the frequency of a specific DP
allele, DPB1"0101, in both our GSE and DH patients over
normal controls supports this possibility. We did not find
increases in DPB1"04 and DPBl"03 alleles in GSE, as reported
by Bugawan et al. (34), nor the increase in DP3 found by
Kagnoffet al. (35), but confirmed the increase in DPl found
by this group. We found DPBl*0101 to be increased, partic-
ularly in association with HLA-DR3, suggesting that the
[HLA-138, SCOT, DR3] extended haplotype often extends
through DP in both GSE (34) and DH (9, 36, 37) patients
as well as in normals (10). In this view, the increase in the
DP marker may be because of known linkage disequili-
brium between [HLA-138, SCOT, DR3] and DP1 (10, 11)
(DPBl"0101) but may also reflect the possibility that the DP
region contains a susceptibility gene (33).
Allele
With
[138, SCO1, DR3]
Without
[138, SCO1, DR3]
With
[138, SCOT, DR3]
Without
[138, SCO1, DR3]
B8 9.8 3.4 7.5 0
SC01 37.8 99.6 8.7 1.7
DR3 10.6 5.4 14.7 11.4
[138, SCO1, DR3] 11 .8 - 10.9 -
1344 1 .1 1.1 1.8 5.0
FC31 1.3 2.5 1.8 0.8
DR7 2.0 19.1 3.5 5.6
[1344, FC31, DR71 2.0 11.4 4.8 6.4
C4A"QO 29.3 50.6 5.9 0.8
DQ2 35.9 6.8 46.9 34.0
Table 6. Extended Haplotype Fragment Distributions in Patients with DH and GSE
SCOT, not DR3,DQ2 DR3,DQ2, not SC01
Disease no. no.
DH 6 1
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